perineal prostatectomy

Albarran was the first surgeon in France to perform a perineal prostatectomy.

He also introduced perineal prostatectomy via lateral incision.

Radical perineal prostatectomy.

George E. Goodfellow (1876), Physician, authority on gunshot wounds, first surgeon to perform a perineal prostatectomy.

He is credited with conceiving of the use of radical perineal prostatectomy to treat prostate cancer and performed the first operation of that kind on April 7, 1904.

He performed the first recorded laparotomy for treating an abdominal gunshot wound and was the first surgeon to perform a perineal prostatectomy to remove an enlarged prostate.

Removal of the entire gland (radical perineal prostatectomy) was first performed in 1904 by Hugh H. Young at Johns Hopkins Hospital.

Surgeries here include repair of rectal prolapse and anterior meningocele, radical perineal prostatectomy, removal of tumors including sacrococcygeal teratoma, and coccygectomy.

The most common types of open prostatectomy are radical retropubic prostatectomy (RRP) and radical perineal prostatectomy (RPP).

Radical perineal prostatectomy is less commonly used than another surgery such as the open radical retropubic prostatectomy or the robot assisted laparoscopic radical retropubic prostatectomy.

During 1891 at St. Mary's Hospital in Tucson, he performed what many consider to be the first perineal prostatectomy, an operation he developed to treat bladder problems by removing the enlarged prostate.

When the cancer is small and confined to the prostate, radical perineal prostatectomy achieves the same rate of cure as the retropubic approach but less blood is lost and recovery is faster.

He performed the first perineal prostatectomy in France, and is credited with introducing the so-called "Albarrán lever", a device used for adjusting the movements of a cystoscope during the catheterization of the ureter.

In patients who are undergoing a radical perineal prostatectomy in whom the PSA value is less than 20 and the Gleason sum is low, however, evidence is mounting that a PLND is probably unnecessary, especially in patients whose malignancy was not palpable but detected on ultrasound.